Cargando…

First person – Chiara Herzog and David Greenald

First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Chiara Herzog and David Greenald are co-first authors on ‘RNA-seq analysis and compound screening highlight mu...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225085/
http://dx.doi.org/10.1242/bio.052654
_version_ 1783534020090396672
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Chiara Herzog and David Greenald are co-first authors on ‘RNA-seq analysis and compound screening highlight multiple signalling pathways regulating secondary cell death after acute CNS injury in vivo’, published in BiO. Chiara is associate business development manager at BioClavis Ltd, Queen Elizabeth University Hospital, Teaching & Learning Centre, Glasgow, working towards making a difference for patients and advancing medicine and diagnostics with innovative technologies. David is a senior research technician in the lab of Dr Rod Mitchell at the Centre for Reproductive Health, The Queen's Medical Research Institute, Edinburgh, investigating small compound screens and how they can be beneficial for academic progress as well as medically relevant.
format Online
Article
Text
id pubmed-7225085
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-72250852020-05-15 First person – Chiara Herzog and David Greenald Biol Open First Person First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Chiara Herzog and David Greenald are co-first authors on ‘RNA-seq analysis and compound screening highlight multiple signalling pathways regulating secondary cell death after acute CNS injury in vivo’, published in BiO. Chiara is associate business development manager at BioClavis Ltd, Queen Elizabeth University Hospital, Teaching & Learning Centre, Glasgow, working towards making a difference for patients and advancing medicine and diagnostics with innovative technologies. David is a senior research technician in the lab of Dr Rod Mitchell at the Centre for Reproductive Health, The Queen's Medical Research Institute, Edinburgh, investigating small compound screens and how they can be beneficial for academic progress as well as medically relevant. The Company of Biologists Ltd 2020-05-04 /pmc/articles/PMC7225085/ http://dx.doi.org/10.1242/bio.052654 Text en © 2020. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Chiara Herzog and David Greenald
title First person – Chiara Herzog and David Greenald
title_full First person – Chiara Herzog and David Greenald
title_fullStr First person – Chiara Herzog and David Greenald
title_full_unstemmed First person – Chiara Herzog and David Greenald
title_short First person – Chiara Herzog and David Greenald
title_sort first person – chiara herzog and david greenald
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225085/
http://dx.doi.org/10.1242/bio.052654